Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v6-FR
Language French French
Date Updated 2021-01-19 2021-01-19
Drug Identification Number 02246699 02246699
Brand name APO-NAPROXEN EC TABLETS APO-NAPROXEN EC TABLETS
Common or Proper name NAPROXEN NAPROXEN
Company Name APOTEX INC APOTEX INC
Ingredients NAPROXEN NAPROXEN
Strength(s) 250MG 250MG
Dosage form(s) TABLET (ENTERIC-COATED) TABLET (ENTERIC-COATED)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 BTL 100 BTL
ATC code M01AE M01AE
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-12-15 2020-12-15
Estimated end date 2021-01-15 2021-01-15
Actual end date 2021-01-15 2021-01-15
Shortage status Resolved Resolved
Company comments
Health Canada comments